Kenyan long-distance runner Geoffrey Yegon has been provisionally suspended by the Athletics Integrity Unit (AIU) for violating anti-doping regulations.
In a statement released on Monday evening, the AIU revealed that Yegon tested positive for Triamcinolone acetonide, a banned substance under World Athletics rules.
“The AIU has provisionally suspended Geoffrey Yegon from Kenya for the presence or use of a prohibited substance, Triamcinolone acetonide,” the AIU stated.
The integrity body reminded athletes of their responsibility to be aware of banned substances, warning that the presence of such substances in their system constitutes a doping offence.
Triamcinolone acetonide is a glucocorticoid commonly used to treat skin conditions by reducing inflammation, redness, and allergic reactions.
It is classified under the 2014 Prohibited List by the World Anti-Doping Agency (WADA) and is banned in competition when administered through injections, oral, or rectal means.
Yegon, 37, secured his first major career win at the Singapore Half Marathon in December 2024, clocking 2 hours, 16 minutes, and 6 seconds. He has also competed in various international road races, including a half marathon in the Netherlands and a 10km race in Germany in 2016.
Photo
Athletics News
His suspension adds to the growing list of Kenyan athletes penalized for doping in recent years. Just two months ago, AIU handed Beatrice Jelagat Cherop a two-year ban for testing positive for the same banned substance.
While Cherop admitted to using the drug unknowingly, leading to a reduced suspension period, other Kenyan athletes such as Elijah Kipkosgei, Sheila Chebet, Esther Gitahi, and Nany Jelaga were also suspended in 2024 for using various prohibited substances, including triamcinolone acetonide, tramadol, Norandrosterone, and Furosemide.
Yegon’s case remains under investigation as authorities determine the next course of action.
